Oncimmune Investors
Oncimmune engaged in developing and commercializing its EarlyCDT platform technology.
Headquarters:
Nottingham, Nottingham, United Kingdom
Technology:
Advanced Longevity (R&D)
Industry:
Advanced and Next Generation Therapies (Various)
Investor Type:
Information Technology Corporation
Founded Date:
2006